Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29


IL-24 contributes to skin inflammation in Para-Phenylenediamine-induced contact hypersensitivity.

Van Belle AB, Cochez PM, de Heusch M, Pointner L, Opsomer R, Raynaud P, Achouri Y, Hendrickx E, Cheou P, Warnier G, Renauld JC, Baeck M, Dumoutier L.

Sci Rep. 2019 Feb 12;9(1):1852. doi: 10.1038/s41598-018-38156-4.


Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells.

Cochez PM, Michiels C, Hendrickx E, Dauguet N, Warnier G, Renauld JC, Dumoutier L.

J Invest Dermatol. 2017 May;137(5):1094-1103. doi: 10.1016/j.jid.2016.12.023. Epub 2017 Jan 20.


AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model.

Cochez PM, Michiels C, Hendrickx E, Van Belle AB, Lemaire MM, Dauguet N, Warnier G, de Heusch M, Togbe D, Ryffel B, Coulie PG, Renauld JC, Dumoutier L.

Eur J Immunol. 2016 Jun;46(6):1449-59. doi: 10.1002/eji.201546070.


IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.

Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, Fouser LA, Renauld JC, Dumoutier L.

J Immunol. 2012 Jan 1;188(1):462-9. doi: 10.4049/jimmunol.1102224. Epub 2011 Nov 30.


Dual TCR expression biases lung inflammation in DO11.10 transgenic mice and promotes neutrophilia via microbiota-induced Th17 differentiation.

Lemaire MM, Dumoutier L, Warnier G, Uyttenhove C, Van Snick J, de Heusch M, Stevens M, Renauld JC.

J Immunol. 2011 Oct 1;187(7):3530-7. doi: 10.4049/jimmunol.1101720. Epub 2011 Aug 22.


IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa.

Steenwinckel V, Louahed J, Lemaire MM, Sommereyns C, Warnier G, McKenzie A, Brombacher F, Van Snick J, Renauld JC.

J Immunol. 2009 Apr 15;182(8):4737-43. doi: 10.4049/jimmunol.0801941.


Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

Näslund TI, Uyttenhove C, Nordström EK, Colau D, Warnier G, Jondal M, Van den Eynde BJ, Liljeström P.

J Immunol. 2007 Jun 1;178(11):6761-9.


IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells.

Steenwinckel V, Louahed J, Orabona C, Huaux F, Warnier G, McKenzie A, Lison D, Levitt R, Renauld JC.

J Immunol. 2007 Mar 1;178(5):3244-51.


Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon.

Nguyen TD, Bigaignon G, Markine-Goriaynoff D, Heremans H, Nguyen TN, Warnier G, Delmee M, Warny M, Wolf SF, Uyttenhove C, Van Snick J, Coutelier JP.

J Med Microbiol. 2003 Oct;52(Pt 10):869-76.


A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18.

Bilsborough J, Panichelli C, Duffour MT, Warnier G, Lurquin C, Schultz ES, Thielemans K, Corthals J, Boon T, van der Bruggen P.

Tissue Antigens. 2002 Jul;60(1):16-24.


Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

Benchetrit F, Ciree A, Vives V, Warnier G, Gey A, Sautès-Fridman C, Fossiez F, Haicheur N, Fridman WH, Tartour E.

Blood. 2002 Mar 15;99(6):2114-21.


The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome.

Schultz ES, Chapiro J, Lurquin C, Claverol S, Burlet-Schiltz O, Warnier G, Russo V, Morel S, Lévy F, Boon T, Van den Eynde BJ, van der Bruggen P.

J Exp Med. 2002 Feb 18;195(4):391-9.


Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes.

Van Pel A, De Plaen E, Duffour MT, Warnier G, Uyttenhove C, Perricaudet M, Boon T.

Cancer Immunol Immunother. 2001 Jan;49(11):593-602.


The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.

Haicheur N, Bismuth E, Bosset S, Adotevi O, Warnier G, Lacabanne V, Regnault A, Desaymard C, Amigorena S, Ricciardi-Castagnoli P, Goud B, Fridman WH, Johannes L, Tartour E.

J Immunol. 2000 Sep 15;165(6):3301-8.


False aneurysm of the left common carotid artery 52 years after penetrating injury of the chest.

Martinod E, Warnier G, Aupecle B, Lajos P, Chapuis O, Pons F, Azorin JF, Jancovici R.

J Trauma. 1999 Aug;47(2):400-2. No abstract available.


Is the correct use of a dry powder inhaler (Turbohaler) age dependent?

De Boeck K, Alifier M, Warnier G.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):763-7.


Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population.

Vink A, Warnier G, Brombacher F, Renauld JC.

J Exp Med. 1999 May 3;189(9):1413-23.


Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice.

Godfraind C, Louahed J, Faulkner H, Vink A, Warnier G, Grencis R, Renauld JC.

J Immunol. 1998 Apr 15;160(8):3989-96.


The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.

Uyttenhove C, Godfraind C, Lethé B, Amar-Costesec A, Renauld JC, Gajewski TF, Duffour MT, Warnier G, Boon T, Van den Eynde BJ.

Int J Cancer. 1997 Jan 27;70(3):349-56.


Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.

Warnier G, Duffour MT, Uyttenhove C, Gajewski TF, Lurquin C, Haddada H, Perricaudet M, Boon T.

Int J Cancer. 1996 Jul 17;67(2):303-10.


Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.

Brichard VG, Warnier G, Van Pel A, Morlighem G, Lucas S, Boon T.

Eur J Immunol. 1995 Mar;25(3):664-71.


Thymic lymphomas in interleukin 9 transgenic mice.

Renauld JC, van der Lugt N, Vink A, van Roon M, Godfraind C, Warnier G, Merz H, Feller A, Berns A, Van Snick J.

Oncogene. 1994 May;9(5):1327-32.


Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas.

Vink A, Renauld JC, Warnier G, Van Snick J.

Eur J Immunol. 1993 May;23(5):1134-8.


Tum- antigens, TSTA, and T cell immune surveillance.

Van Pel A, Warnier G, Van den Eynde B, Lethé B, Lurquin C, Boon T.

Ann N Y Acad Sci. 1991 Dec 30;636:43-51. Review. No abstract available.


Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.

Vink A, Coulie P, Warnier G, Renauld JC, Stevens M, Donckers D, Van Snick J.

J Exp Med. 1990 Sep 1;172(3):997-1000.


IgG2a restriction of murine antibodies elicited by viral infections.

Coutelier JP, van der Logt JT, Heessen FW, Warnier G, Van Snick J.

J Exp Med. 1987 Jan 1;165(1):64-9.


Rheumatoid factor production in 129/Sv mice: involvement of an intestinal infectious agent.

Coutelier JP, Van der Logt JT, Heessen FW, Warnier G, Van Snick J.

J Immunol. 1986 Jul 1;137(1):337-40.


Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes.

Vessière F, Georlette M, Warnier G, Leclerc JC, Van Pel A, Boon T.

Eur J Cancer Clin Oncol. 1982 Sep;18(9):867-74.


[Need for and portrait of the federation].

Warnier G.

Nursing (Brux). 1972 May-Jun;44(3):46-7. French. No abstract available.


Supplemental Content

Loading ...
Support Center